Nitto Denko Asia Technical Centre Pte Ltd [referred as NAT] was set up in Singapore since September 2008 with the full support of Nitto Corporation Japan (TYO:6988) and further expanded its operations in Thailand, with Singapore being the headquarters. The Company business mission is in the eradication of chronic diseases by tackling both the mind (mental health) and body (physical health) of mankind under the branding of Zensorium. On mental health; NAT is launching its non-medical wearable product called “Self by Zensorium”. Through our proprietary pulse shape analysis, our wearable device provides unique insights into your stress and advanced sleep stages.
On physical health; “ACT by Zensorium” is a point-of-care urinalysis device that conveniently measures Urinary Albumin & Creatinine Ratio allowing early detection of kidney deterioration. The beta version will be ready for testing in late 2019.